Michels AW et al., T-cell responses to hybrid insulin peptides prior to type 1 diabetes development. Proc Natl Acad Sci U S A. 2021.

Gottlieb PA, Michels AW. Advances in Diabetes Treatment - Once-Weekly Insulin. N Engl J Med. 2020.

Mitchell AM, Michels AW. T cell receptor sequencing in autoimmunity. J Life Sci. 2020.

Wentworth JM, Gottlieb PA, et al., Clinical trial data validate the C-peptide estimate model in type 1 diabetes. Diabetologia. 2020.

Triolo TM, Gottlieb PA, et al., Risk of Islet and Celiac Autoimmunity in Cotwins of Probands With Type 1 Diabetes. J Endocr Soc. 2020.

Ostrov DA, Gottlieb PA, Michels AW. Rationally designed small molecules to prevent type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2019.

Nakayama M, Michels AW. Determining Antigen Specificity of Human Islet Infiltrating T Cells in Type 1 Diabetes. Front Immunol. 2019.

Baker RL, Michels A, Gottlieb Paet al., Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes. Diabetes. 2019.

Michels AW, Gottlieb PA. Learning From Past Failures of Oral Insulin Trials. Diabetes. 2018.

Ostrov DA, Gottlieb PA, Michels AW et al., Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. J Clin Invest. 2018.

IM Therapeutics White Paper. Targeting Human Leukocyte Antigen (HLA) DQ8 for Type 1 Diabetes. 2017

Michels AW, Gottlieb PA, et al., Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes. Diabetes. 2017.

Atkinson MA, Eisenbarth GS, Michels AW. Type 1 Diabetes. Lancet. 2014.  

Liu E, Michels AW et al., Exploring T cell reactivity to gliadin in young children with newly diagnosed celiac disease. Autoimmune Dis. 2014.

Michels AW. Targeting the trimolecular complex. Clin Immunol. 2013.